The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells
- PMID: 12874827
- DOI: 10.1002/jcb.10580
The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells
Abstract
Vitamin D is a potent immune system regulator. The active form of vitamin D (1,25(OH)(2)D(3)) suppresses the development of animal models of human autoimmune diseases. 1,25(OH)(2)D(3) decreased the proliferation of all T helper (h) cells and decreased the production of IFN-gamma, IL-2, and IL-5. In Th2 cells 1,25(OH)(2)D(3) increased the production of IL-4. Quiescent CD4+ T cells express vitamin D receptors but only at a low level, which increased five-fold following activation. 1,25(OH)(2)D(3) treatment of Th0 cells, but not Th1 or Th2 cells, induced the expression of the transcription factor GATA-3. Microarray technology identified over 102 targets of 1,25(OH)(2)D(3) in CD4+ T cells. Of the 102 genes, 57 genes were down-regulated and 45 were up-regulated by 1,25(OH)(2)D(3) treatment of the CD4+ T cells. Two of the identified genes are regulators of NFkB. Other genes of interest included the IL-2Rbeta gene and IgE binding factor. Th2 and Th0 cells produced more IgE binding factor after treatment with 1,25(OH)(2)D(3) while Th1 cell IgE binding factor expression was unaffected by 1,25(OH)(2)D(3) addition. It is unclear why some of the genes identified are expressed in CD4+ T cells and furthermore why 1,25(OH)(2)D(3) regulates the expression of these genes. Clearly CD4+ T cells can be direct targets of vitamin D. The targets of vitamin D in CD4+ T cells depend on the state of activation and differentiation status of the cells.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.J Ethnopharmacol. 2009 May 4;123(1):6-14. doi: 10.1016/j.jep.2009.02.045. Epub 2009 Mar 9. J Ethnopharmacol. 2009. PMID: 19429332
-
Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma.J Immunol. 1997 Mar 1;158(5):2090-8. J Immunol. 1997. PMID: 9036953
-
Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.J Leukoc Biol. 2005 Sep;78(3):656-64. doi: 10.1189/jlb.1104631. Epub 2005 Jun 16. J Leukoc Biol. 2005. PMID: 15961574
-
GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors.Cell Res. 2006 Jan;16(1):3-10. doi: 10.1038/sj.cr.7310002. Cell Res. 2006. PMID: 16467870 Review.
-
[Vitamin D and the immune system].Pathol Biol (Paris). 1994 Feb;42(2):163-72. Pathol Biol (Paris). 1994. PMID: 8090562 Review. French.
Cited by
-
Multifaceted Roles of Vitamin D for Diabetes: From Immunomodulatory Functions to Metabolic Regulations.Nutrients. 2024 Sep 20;16(18):3185. doi: 10.3390/nu16183185. Nutrients. 2024. PMID: 39339785 Free PMC article. Review.
-
Skewed epithelial cell differentiation and premature aging of the thymus in the absence of vitamin D signaling.Sci Adv. 2024 Sep 27;10(39):eadm9582. doi: 10.1126/sciadv.adm9582. Epub 2024 Sep 25. Sci Adv. 2024. PMID: 39321290 Free PMC article.
-
Developmental Vitamin D Deficiency and the Vitamin D Receptor Control Hematopoiesis.J Immunol. 2024 Nov 15;213(10):1479-1487. doi: 10.4049/jimmunol.2400292. J Immunol. 2024. PMID: 39320233
-
Association between serum vitamin D status and severity of liver cirrhosis: implications for therapeutic targeting in Nigerian patients.BMC Gastroenterol. 2024 Aug 12;24(1):259. doi: 10.1186/s12876-024-03353-1. BMC Gastroenterol. 2024. PMID: 39135191 Free PMC article.
-
High-dose vitamin D3 supplementation shows no beneficial effects on white blood cell counts, acute phase reactants, or frequency of respiratory infections.Respir Res. 2024 Jan 4;25(1):11. doi: 10.1186/s12931-023-02642-9. Respir Res. 2024. PMID: 38178229 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials